Inmune Bio, Inc. business relationships
Companies named in Inmune Bio, Inc.’s 10-K filed 2026-03-30, and public companies whose annual reports name Inmune Bio, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 5 / 100 Top 3% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Inmune Bio, Inc.’s annual report 1
“entered into a license agreement with Xencor, Inc. ("Xencor"), which has discovered and developed a proprietary biological” SEC filing
Companies whose annual reports name Inmune Bio, Inc. 1
“| Mutual Termination of License Agreement dated as of February 27, 2025, by and between the Company and INmune Bio, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Fork 8-K, filed with the SEC on March 3, 2025) |” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.